1. Search Result

Search Result

Results for "1013920-15-4" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-109019

    CM082; X-82

    VEGFR PDGFR Cancer
    Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death.